<DOC>
	<DOC>NCT02502721</DOC>
	<brief_summary>A randomized, open-labeled, oral dose, crossover design clinical trial to evaluate pharmacokinetics and safety between DWC20151 and DWC20152 in healthy male subjects.</brief_summary>
	<brief_title>A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152</brief_title>
	<detailed_description>This study is to evaluate pharmacokinetics and safety between DWC20151 and DWC20152 in healthy male subjects. Study design is randomized, open-labeled, oral dose, crossover design. This study will conducted with 2 separated part (Part A, Part B).</detailed_description>
	<criteria>Healthy male subjects (18~55 years) Who has allergy to investigational product</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Male</keyword>
</DOC>